Pidotimod

Spezifikationen

121808-62-6CAS-Nummer

629-822-3EG-Nummer

(4R)-3-[(2S)-5-oxopyrrolidine-2-carbonyl]-1,3-thiazolidine-4-carboxylic acidIUPAC-Name

C9H12N2O4SChemische Formel

244.27 g/molMolekulargewicht

Pidotimod; 121808-62-6; Pidotimodum; Pilimod; DTXSID0046199; NSC-759841; DTXCID8026199; (4R)-3-[(2S)-5-oxopyrrolidine-2-carbonyl]-1,3-thiazolidine-4-carboxylic acid; 785363R681; Pgt-1A; (4R)-3-((2S)-5-oxopyrrolidine-2-carbonyl)-1,3-thiazolidine-4-carboxylic acid; RefChem:174211; 3-((5-Oxo-2-pyrrolidinyl)carbonyl)-4-thiazolidinecarboxylic acid; L03AX05; 3-Pyroglutamylthiazolidine-4-carboxylic acid; Pidotomod; (R)-3-((S)-5-Oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylic acid; Polimod; PGT/1A; Pidotimod [INN]; Axil; MFCD00867583; (R)-3-((S)-5-Oxoprolyl)-4-thiazolidinecarboxylic acid; Pidotimod (INN); (4R)-3-[[(2S)-5-OXO-2-PYRROLIDINYL]CARBONYL]-4-THIAZOLIDINECARBOXYLIC ACID; NCGC00160516-01; Pigitil; Adimod; Pidotimodum [INN-Latin]; SMR000466390; CCRIS 7271; BRN 6636310; Onaka; Thymodolic acid; Timodolic acid; Pigitil;; Onaka;; Axil;; Pilimod (TN); UNII-785363R681; Pidotimod (Standard); PIDOTIMOD [MI]; PIDOTIMOD [MART.]; (R-(R*,S*))-3-((5-Oxo-2-pyrrolidinyl)carbonyl)-4-thiazolidinecarboxylic acid; PIDOTIMOD [WHO-DD]; (R)-3-((S)-(5-Oxo-2-pyrrolidinyl)carbonyl)-thiazolidin-4-carbonsaeure [German]; MLS000759528; MLS001032108; MLS001216453; MLS001423953; SCHEMBL138407; Pidotimod - Bio-X trade mark; orb1226775; orb1308296; CHEMBL1488165; Pidotimod, >=98% (HPLC); SCHEMBL27588626; SCHEMBL28339242; CHEBI:94618; HY-B0944R; GLXC-05213; HMS2051C04; HMS2231M03; HMS3715H06; Pharmakon1600-01502322; HY-B0944; Tox21_111865; BIO-7488?; MSK163305; NSC759841; s3106; (4R)-3-[(2S)-5-oxopyrrolidine-2-carbonyl]thiazolidine-4-carboxylic acid; (R)-3-((S)-(5-Oxo-2-pyrrolidinyl)carbonyl)-thiazolidin-4-carbonsaeure; AKOS015896354; AC-3493; CCG-100832; DB11364; FP27040; KS-5229; NC00082; NSC 759841; (4R)-3-{[(2S)-5-oxopyrrolidin-2-yl]carbonyl}-1,3-thiazolidine-4-carboxylic acid; (R)-3-[[(S)-5-Oxo-2-pyrrolidinyl]carbonyl]-1,3-thiazolidine-4-carboxylic Acid; 4-Thiazolidinecarboxylic acid, 3-((5-oxo-2-pyrrolidinyl)carbonyl)-, (R-(R*,S*))-; NCGC00160516-03; BP164260; SY109010; CAS-121808-62-6; NS00069185; P2147; P3313; SW197462-2; T1532; D07261; AB00639966-08; AB00639966_10; AB00639966_11; F211857; Q3902720; BRD-K44442813-001-11-1; BRD-K44442813-001-12-9; (4R)-3-(5-oxo-L-prolyl)-1,3-thiazolidine-4-carboxylic acid; (4R)-3-[oxo-[(2S)-5-oxo-2-pyrrolidinyl]methyl]-4-thiazolidinecarboxylic acid; 4-Thiazolidinecarboxylic acid, 3-[[(2S)-5-oxo-2-pyrrolidinyl]carbonyl]-, (4R)-; (4R)-3-{[(2S)-5-OXOTETRAHYDRO-1H-PYRROL-2-YL]CARBONYL}-1,3-THIAZOLANE-4-CARBOXYLIC ACIDSynonyme